Myriad Genetics, Inc. , a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally.
Myriad Genetics stock last closed at $12.93, up 4.19% from the previous day, and has decreased 40.82% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.19 percentage points. Myriad Genetics stock is currently +7.39% from its 52-week low of $12.04, and -55.87% from its 52-week high of $29.30.
At the moment, there are 91.04M shares of MYGN outstanding. The market value of MYGN is $1.18B. In the past 24 hours, 1.09M MYGN shares were traded.
How to Buy Myriad Genetics Stock
Not sure how to invest in Myriad Genetics stock? Here's how.
Choose where to buy Myriad Genetics stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you determine where to buy Myriad Genetics stock.
Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Put funds into your investment account: Pick your method of payment and add your information.
Evaluate Myriad Genetics stock: The Myriad Genetics ticker symbol is MYGN. Is Myriad Genetics stock a good investment? Should you buy shares of MYGN? How do MYGN's underlying business fundamentals look? Do top analysts think Myriad Genetics is a good buy? Why has MYGN's stock price moved recently? (Hint: Our stock research website can help you evaluate if MYGN is a good stock to buy).
Place your MYGN trade: Decide if you will purchase MYGN shares at the current market price or use a limit order to purchase MYGN shares at a given price.
Keep an eye on your MYGN investment: Create a watchlist to monitor your new investment in Myriad Genetics stock.
Step 1: Choose where to buy Myriad Genetics stock
You need an online brokerage account in order to access the NASDAQ market and buy MYGN shares.
A brokerage account enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to global financial markets: From Technology to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal info so you can invest in MYGN today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Myriad Genetics stock
Once you have figured out the best place to buy Myriad Genetics stock, it's absolutely critical to research their stock prior to investing, so you actually wrap your head around the risk and opportunity.
Myriad Genetics Metrics
MYGN Price
$12.93
1w %
3.11%
1y %
-40.82%
5y %
-56.21%
P/E
-10.1x
P/B
1.61x
P/S
1.43x
PEG
N/A
Revenue
$823.60M
Earnings
-$116.00M
Fore. Rev. Growth
8.19%
Fore. Earn. Growth
N/A
Market Cap
$1.18B
Next Earnings
Feb 25, 2025
Next Dividend
N/A
Myriad Genetics Fundamentals
WallStreetZen was created to help average investors do better fundamental analysis quickly.
There are more short-term assets than long-term liabilities on the MYGN balance sheet.
MYGN profit margin has gone up from -37.4% to -14.1% in the past year.
There are more short-term assets than short-term liabilities on the MYGN balance sheet.
Total MYGN debt is lower than 5 years ago, relative to shareholder equity.
Failed Financial Due Diligence Checks:
MYGN has cash burn of 107300000. It does not have enough cash and short-term investments to cover this.
MYGN has a relatively high debt to equity ratio of 0.48.
MYGN has $99.90M in cash and short term investments. This is not sufficient to cover its annual cash burn of $107.30M.
Do analysts think it's a good time to buy Myriad Genetics stock
Out of 10 Equities analysts who give forecasts on MYGN, the consensus analyst rating on Myriad Genetics is a Hold
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent MYGN Analyst Forecasts
Puneet Souda, a bottom 2% analyst from Leerink Partners downgrades MYGN to a hold rating and lowers their MYGN price target from $30.00 to $21.00, on Dec 9, 2024.
Tejas Savant, a bottom 8% analyst from Morgan Stanley maintains MYGN with a hold rating and lowers their MYGN price target from $32.00 to $21.00, on Nov 18, 2024.
Brandon Couillard, a top 31% analyst from Wells Fargo initiates coverage on MYGN with a strong buy rating and announces their MYGN price target of $35.00, on Aug 27, 2024.
Sung Ji Nam, a bottom 8% analyst from ScotiaBank maintains MYGN with a buy rating and raises their MYGN price target from $29.00 to $34.00, on Aug 13, 2024.
Dan Brennan, a top 18% analyst from TD Cowen maintains MYGN with a hold rating and raises their MYGN price target from $28.00 to $30.00, on Aug 7, 2024.
Last year, MYGN revenue was $823.60M. During the past 5 year, MYGN's revenue has gone up by -0.28% per year. This was slower than the Diagnostics & Research industry average of 9.85%.
No, Myriad Genetics doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your MYGN trade
You have two primary order types:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are usually fine.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a particular dollar amount, place a limit order.
Click the Open button and your broker will place your order.
If you want more help investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Myriad Genetics share?
As of Feb 5, 2025, it costs $12.93 to buy one share of Myriad Genetics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $6, you can buy 0.464 shares of MYGN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.